Innovation and translation are at the forefront of work at LSTM as it aims to discover and develop, then go forward with implementation of its innovative ideas. In doing so, LSTM considers itself unique in spanning the translational pipeline from discovery to implementation.
News article
Transmission risk of COVID-19 from sports equipment
Transmission risk of COVID-19 from sports equipment
A team, led by Liverpool School of Tropical Medicine's Dr Emily Adams, has investigated the transmission risk of COVID-19 from sports equipment,...
News article
Dr Fiona Marston becomes LSTM’s Entrepreneur in Residence
Dr Fiona Marston becomes LSTM’s Entrepreneur in Residence
Dr Fiona Marston is to become LSTM’s Entrepreneur in Residence after being awarded a place on the Royal Society’s scheme for 2021.
News article
Volunteer for the COM COV Clinical Trial
Volunteer for the COM COV Clinical Trial
COM COV Clinical Trial Oxford Vaccine Group at LSTM
News article
World's first COVID-19 vaccine alternating dose study launches in Liverpool
World's first COVID-19 vaccine alternating dose study launches in Liverpool
COVID-19 vaccine alternating dose study launched today in the UK
News article
LSTM researchers investigate the impact of pneumococcal colonisation on immune responses to live attenuated influenza vaccine
LSTM researchers investigate the impact of pneumococcal colonisation on immune responses to live attenuated influenza vaccine
LSTM researchers, led by Dr Elena Mitsi, have investigated the impact of pneumococcal colonisation on immune responses to live attenuated influenza...
News article
Excalibur rapid SARS-COV-2 antigen screening test, validated by LSTM, granted MHRA approval
Excalibur rapid SARS-COV-2 antigen screening test, validated by LSTM, granted MHRA approval
Excalibur Healthcare Services Ltd, a UK-based provider of high-quality medical products and services, has announced that its Rapid SARS COV-2 Antigen...
News article
Mologic Receives CE Mark Approval for Professional-Use COVID-19 Rapid Antigen Test
Mologic Receives CE Mark Approval for Professional-Use COVID-19 Rapid Antigen Test
News article
New spray, co-developed with the British Army and tested by LSTM, kills coronavirus in under 60 seconds
New spray, co-developed with the British Army and tested by LSTM, kills coronavirus in under 60 seconds
An Essex inventor working alongside the British Army has created a ‘military grade’ disinfectant spray, tested by LSTM, which kills all coronavirus...
News article
Drug combination protects mice from the lethal effects of snakebite caused by geographically diverse snake species
Drug combination protects mice from the lethal effects of snakebite caused by geographically diverse snake species
Researchers at LSTM’s Centre for Snakebite Research and Interventions (CSRI) have found that a combination of toxin inhibitors could provide the...
News article
Oxford Covid vaccine 'safe and effective', Lancet study shows
Oxford Covid vaccine 'safe and effective', Lancet study shows
Vaccine researchers at LSTM want to say a huge thank you to all of the participants and volunteers who took part in the Phase III Oxford COVID-19...
News article
LSTM Annual Report and Financial Statements 2019-2020
LSTM Annual Report and Financial Statements 2019-2020
The LSTM Annual Report and Financial Statements 2019-2020 are now available
News article
First partner meeting of iiCON, the Infection Innovation Consortium
First partner meeting of iiCON, the Infection Innovation Consortium
The new multimillion-pound Infection Innovation Consortium (iiCON), had its initial partner meeting, setting the agenda of their work over the next...
News article
LSTM partner in national ‘Decade of Health’ campaign
LSTM partner in national ‘Decade of Health’ campaign
LSTM is proud to be a part of a new campaign funded by the Bill & Melinda Gates Foundation which highlights the research being carried out in the...
News article
LSTM researchers find an easy alternative to nasal and throat swabbing for SARS-CoV-2 Diagnosis
LSTM researchers find an easy alternative to nasal and throat swabbing for SARS-CoV-2 Diagnosis
Researchers from LSTM, working alongside clinical and research staff at the Royal Liverpool and Aintree University Hospitals, have found that saliva...
News article
LSTM's third virtual symposium on Global Health Research & Vaccination: Private sector partnership, research and accelerating the development of new tools
LSTM's third virtual symposium on Global Health Research & Vaccination: Private sector partnership, research and accelerating the development of new tools
LSTM hosted the last in a series of online symposia that addressed the role of research in vaccine development and delivery and the creation of...
News article
LSTM named as a site for Phase III of the Oxford COVID-19 vaccine human trials
LSTM named as a site for Phase III of the Oxford COVID-19 vaccine human trials
LSTM has begun recruiting frontline health and social care workers to take part in a COVID-19 vaccine trial.
News article
LSTM announces the recipients of the Director’s Catalyst Fund (DCF) 2020
LSTM announces the recipients of the Director’s Catalyst Fund (DCF) 2020
LSTM’s Director’s Catalyst Fund (DCF) 2020 awards have been selected. This year, six awards will be allocated to early career researchers pursuing...
News article
LSTM & World Immunization Week 2020
LSTM & World Immunization Week 2020
During World Immunization Week we celebrate vaccines and the role of vaccine researchers in Global Health. We take this opportunity to celebrate some...
Media
BBC Radio Merseyside's SciFri with Rachel Byrne MRC/DTP PhD candidate
BBC Radio Merseyside's SciFri with Rachel Byrne MRC/DTP PhD candidate
LSTM’s Rachel Byrne featured on SciFri on the 3rd April at 7:05am. Rachel talks about her work supporting the Covid-19 research efforts at LSTM.
News article
LSTM begins the validation process for the Mologic COVID-19 point-of-need diagnostic test
LSTM begins the validation process for the Mologic COVID-19 point-of-need diagnostic test
Independent assessment and validation of COVID-19 diagnostic test has been initiated at LSTM by Dr. Emily Adams and her research group, along with...
News article
“Antibodies will make a significant contribution to design effective control strategies for COVID-19”
“Antibodies will make a significant contribution to design effective control strategies for COVID-19”
LSTM’s Professor Richard Pleass has been interviewed by ProteoGenix about how his ground-breaking work leveraging the Fc region of antibodies could...
News article
LSTM’s HiVE Innovation programme celebrates its inaugural cohort
LSTM’s HiVE Innovation programme celebrates its inaugural cohort
On 3rd March, guests gathered in Accra, Ghana, to celebrate the achievements of the inaugural cohort of the Health Innovation in a Virtual...
News article
Missed the LSTM Seminar on Tiny Targets – from a research project to large scale vector control implementation? Watch it here
Missed the LSTM Seminar on Tiny Targets – from a research project to large scale vector control implementation? Watch it here
News article
LSTM's Dr Ryan Robinson nominated in the 2020 North West Research and Innovation Awards
LSTM's Dr Ryan Robinson nominated in the 2020 North West Research and Innovation Awards
Clinical Research Fellow at LSTM, Dr Ryan Robinson, has been nominated for a Rising Star award for 2020 North West Research and Innovation Awards.
